News
December 05, 2025
Agilent and Monash University Malaysia Mark 15-Year Partnership with New BioDiscovery Hub to Drive Regional Biotech Innovation
Collaboration aimed at accelerating R&D in both small- and large-molecule analysis and building high-impact capabilities in fast-growing Asian markets KUALA LUMPUR, Malaysia, Dec. 5, 2025 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) announced the expansion of their strategic collaboration wi...
KUALA LUMPUR, Malaysia – A new BioDiscovery Hub is set to boost biotechnology innovation in Southeast Asia, thanks to a deepened partnership between Agilent Technologies Inc. and Monash University Malaysia. The announcement, made on December 5, 2025, marks a significant milestone in their 15-year relationship, solidifying their commitment to advancing research and development in the region.
The collaboration focuses on accelerating breakthroughs in both small- and large-molecule analysis, crucial areas for developing new drugs and therapies. By combining Agilent's cutting-edge analytical technologies with Monash University Malaysia's research expertise, the BioDiscovery Hub aims to build high-impact capabilities, particularly in the rapidly expanding Asian markets.
The new hub will serve as a central point for researchers, scientists, and students to access state-of-the-art equipment and collaborative opportunities. This will empower them to conduct advanced research in areas like drug discovery, personalized medicine, and diagnostics. The partnership aims to address critical healthcare challenges and contribute to economic growth in the region.
Agilent's role in the collaboration involves providing advanced analytical instrumentation, software, and support services. This includes mass spectrometry, chromatography, and other essential tools for analyzing complex biological samples. Monash University Malaysia will contribute its research expertise, infrastructure, and access to talented researchers and students.
The BioDiscovery Hub is expected to foster a vibrant ecosystem of innovation, attracting talent and investment to the region. By providing a platform for collaboration and knowledge sharing, the partnership aims to accelerate the translation of research findings into practical applications that benefit society.
This strategic collaboration between Agilent and Monash University Malaysia highlights the importance of industry-academia partnerships in driving scientific progress and addressing global challenges. The BioDiscovery Hub is poised to become a leading center for biotechnology innovation in Southeast Asia, contributing to advancements in healthcare and beyond. The expanded partnership underscores both organizations’ long-term commitment to supporting scientific discovery and developing the next generation of biotech leaders.
The collaboration focuses on accelerating breakthroughs in both small- and large-molecule analysis, crucial areas for developing new drugs and therapies. By combining Agilent's cutting-edge analytical technologies with Monash University Malaysia's research expertise, the BioDiscovery Hub aims to build high-impact capabilities, particularly in the rapidly expanding Asian markets.
The new hub will serve as a central point for researchers, scientists, and students to access state-of-the-art equipment and collaborative opportunities. This will empower them to conduct advanced research in areas like drug discovery, personalized medicine, and diagnostics. The partnership aims to address critical healthcare challenges and contribute to economic growth in the region.
Agilent's role in the collaboration involves providing advanced analytical instrumentation, software, and support services. This includes mass spectrometry, chromatography, and other essential tools for analyzing complex biological samples. Monash University Malaysia will contribute its research expertise, infrastructure, and access to talented researchers and students.
The BioDiscovery Hub is expected to foster a vibrant ecosystem of innovation, attracting talent and investment to the region. By providing a platform for collaboration and knowledge sharing, the partnership aims to accelerate the translation of research findings into practical applications that benefit society.
This strategic collaboration between Agilent and Monash University Malaysia highlights the importance of industry-academia partnerships in driving scientific progress and addressing global challenges. The BioDiscovery Hub is poised to become a leading center for biotechnology innovation in Southeast Asia, contributing to advancements in healthcare and beyond. The expanded partnership underscores both organizations’ long-term commitment to supporting scientific discovery and developing the next generation of biotech leaders.
Category:
Technology